Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Xeomin 100unit powder for solution for injection vials (Merz Pharma UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Xeomin 100unit powder for solution for injection vials (Merz Pharma UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clarithromycin 500mg powder for solution for infusion vials (PLIVA Pharma Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clarithromycin 500mg powder for solution for infusion vials (PLIVA Pharma Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pralidoxime chloride 1g powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Protopam Chloride 1g powder for solution for injection vials (Imported (United States)) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pralidoxime chloride 1g powder for solution for injection vials 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Protopam Chloride 1g powder for solution for injection vials (Imported (United States)) 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftriaxone 250mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clarithromycin 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 2g powder for solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 25 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clarithromycin 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftriaxone 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 2g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftriaxone 250mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefotaxime 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (PLIVA Pharma Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (PLIVA Pharma Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Urokinase 250000iu powder for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Solivito N powder for concentrate for solution for infusion vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solivito N powder for concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solu-Medrone 500mg powder and solvent for solution for injection vials (Waymade Healthcare Plc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solu-Medrone 500mg powder and solvent for solution for injection vials (Waymade Healthcare Plc) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fosaprepitant 115mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fosaprepitant 115mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydrocortisone sodium succinate 100mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solu-Cortef 100mg powder for solution for injection vials (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 500mg powder for solution for injection ampoules (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 100mg powder for solution for injection ampoules (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydrocortisone sodium succinate 100mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Solu-Cortef 100mg powder for solution for injection vials (Pfizer Ltd) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 500mg powder for solution for injection ampoules (Actavis UK Ltd) 5 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 100mg powder for solution for injection ampoules (Actavis UK Ltd) 5 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 2,000unit powder and solvent for solution for injection vials (Takeda UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 3,000unit powder and solvent for solution for infusion vials (Takeda UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Octocog alfa 3,000unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 2,000unit powder and solvent for solution for injection vials (Takeda UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Advate 3,000unit powder and solvent for solution for infusion vials (Takeda UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftazidime 1g powder for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftazidime 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 250,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 50,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eptacog alfa (activated) 1mg (50,000unit) powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 250,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NovoSeven 50,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Desferal 500mg powder for solution for injection vials (Sigma Pharmaceuticals Plc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Desferal 500mg powder for solution for injection vials (Sigma Pharmaceuticals Plc) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alimta 100mg powder for concentrate for solution for infusion vials (Eli Lilly and Company Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pemetrexed 100mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alimta 100mg powder for concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (medac UK) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 150mg powder for solution for infusion vials (medac UK) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (medac UK) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 150mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftazidime 2g powder for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 100mg powder for solution for infusion vials (medac UK) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 150mg powder for solution for infusion vials (medac UK) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (medac UK) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ceftazidime 2g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epirubicin 50mg powder for solution for injection vials (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludarabine phosphate 50mg powder for solution for injection vials (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epirubicin 10mg powder for solution for injection vials (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (Actavis UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludarabine phosphate 50mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epirubicin 50mg powder for solution for injection vials (Actavis UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxaliplatin 50mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludarabine phosphate 50mg powder for solution for injection vials (Actavis UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epirubicin 10mg powder for solution for injection vials (Actavis UK Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Omeprazole 40mg powder for solution for infusion vials (Teva UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Omeprazole 40mg powder for solution for infusion vials (Teva UK Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Auralis Ltd) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Chiron Vaccines Evans) 100 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine hydrochloride 5mg injection |
Has dispensed dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Chiron Vaccines Evans) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Actavis UK Ltd) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Auralis Ltd) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules 100 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Unichem Plc) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Unichem Plc) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Unichem Plc) 100 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Chiron Vaccines Evans) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (Actavis UK Ltd) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 5mg powder for solution for injection ampoules (C P Pharmaceuticals Ltd) 5 ampoule |
Has dispensed dose form |
True |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|